Fact CheckerSign in

NCT07014891Recruiting

fNIRS-Driven Visual Feedback Training to Restore Walking After Stroke

A Study on Visual Feedback Motor Control Training Using Near-Infrared Spectroscopy (fNIRS) Brain Functional Imaging for Walking Function Recovery in Stroke Patients

Source: ClinicalTrials.gov · Last updated 24 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The objective of this clinical trial is to investigate whether intelligent visual feedback-based lower limb motor control training is more effective than conventional rehabilitation training in promoting walking ability recovery among stroke patients with hemiplegia. The trial aims to address the primary question of the impact of intelligent visual feedback motor control training on the walking function of stroke patients with hemiplegia, and uses three-dimensional gait analysis for precise quantitative evaluation of therapeutic effects. Functional near-infrared spectroscopy (fNIRS) will be employed to explore patients' cerebral functional connectivity and cortical activation, and to analyze the correlation between fNIRS data and walking function scores (such as those from three-dimensional gait analysis), providing effective methods and a reliable reference basis for rehabilitation training of post-stroke hemiplegic patients. Participants will be randomly divided into two groups: the experimental group receiving intelligent visual feedback motor control training, and the control group receiving Bobath ball training, 20 minutes per day, 5 days per week, for a total of four weeks. Before and after the treatment, indicators including fNIRS brain functional imaging, three-dimensional gait analysis, and Fugl-Meyer Assessment will be evaluated.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
44 (estimated)
First submitted
3 Jun 2025
Start date
Dec 2024
Primary completion date
Dec 2025
Lead sponsor
Shengjing Hospital
Diseases
Stroke
NCT number
NCT07014891

What you commit to

  • Study type: Interventional
  • Planned participants: 44
  • From Dec 2024 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1: Patients with tumors, tuberculosis, hematological diseases, or functional impairments of vital organs such as the heart or liver.
    • 2: Those with lower limb musculoskeletal disorders, such as knee arthritis or lower limb fractures.
    • 3: Individuals with severe abnormal muscle tone in the limbs or joint contracture deformities.
    • 4: Patients experiencing severe pain that prevents them from tolerating physical activity.
    • 5: Special populations, such as individuals with mental illnesses, breastfeeding women, or pregnant women.

Who the study is looking for

  • 1: Vital signs are stable, with no severe cardiopulmonary diseases, making the patient suitable for exercise testing.
    • 2: All patients are diagnosed with stroke by head CT or MRI, with clinical manifestations of unilateral limb hemiplegia.
    • 3: The Brunnstrom stage of the lower limb is 3-5, quadriceps muscle strength is ≥ grade 3, modified Ashworth scale for the lower limb is \< grade 2, and Hoffer walking scale is ≥ grade 2.
    • 4: This is their first onset of the disease, with a disease course of ≤ 6 months, and the condition is stable.
    • 5: Patients have no severe cognitive impairment or sensory aphasia, can understand and actively participate in the training program, and have provided informed consent by signing the consent form for this clinical study.
    • 6: Age: 18-75 years old, no gender restrictions.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rehabilitation Center of Shengjing Hospital, China Medical University
Coordinator of this site? Confirm its status
ShenyangChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.